Etamsylate: Mechanism of action and Pharmacology

Once the etamsylate is administered, it is slowly absorbed in the gastrointestinal tract. Following oral administration of 500 mg of ethamsilate, the utmost level in plasma, for instance 151 μg / ml, is reached at 4 h, but bioavailability is not known.

The holding speed to plasma proteins is approximately 95%. The plasma half-life is approximately 3. 7 h. About 72% of the administered medication dosage is excreted in the first 24 h in the urine, the particle is excreted without changes.

Etamsylate crosses the placental barrier. Maternal and umbilical cord blood contains similar concentrations of etamsylate.

This is not known if etamsylate is excreted in breast milk.

It is not known whether or not the pharmacokinetic properties of etamsylate are modified in patients struggling from impaired renal or hepatic function.

The Dicynone tablet boosts the patient’s condition by performing the following functions:

Improvement of the adhesiveness of platelets and restoration of capillary resistance.
Ethamsato.
Keep in mind that this medication may be available in several strengths for every lively ingredient mentioned above.